TGTX logo

TG Therapeutics, Inc. (TGTX) Return On Equity

Annual ROE:

12.21%+0.64%(+5.53%)
December 31, 2024

Summary

  • As of today, TGTX annual return on equity is 12.21%, with the most recent change of +0.64% (+5.53%) on December 31, 2024.
  • During the last 3 years, TGTX annual ROE has risen by +104.24% (+113.27%).
  • TGTX annual ROE is now -87.48% below its all-time high of 97.55%, reached on December 31, 2008.

Performance

TGTX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXprofitability metrics

Quarterly ROE:

27.34%+7.56%(+38.22%)
June 30, 2025

Summary

  • As of today, TGTX quarterly return on equity is 27.34%, with the most recent change of +7.56% (+38.22%) on June 30, 2025.
  • Over the past year, TGTX quarterly ROE has dropped by -40.68% (-59.81%).
  • TGTX quarterly ROE is now -99.81% below its all-time high of 14.73 thousand%, reached on September 30, 2003.

Performance

TGTX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TGTX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+5.5%-59.8%
3Y3 Years+113.3%+123.3%
5Y5 Years+102.2%+105.8%

TGTX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+109.1%-59.8%+111.1%
5Y5-Yearat high+102.2%-59.8%+108.9%
All-TimeAll-Time-87.5%+100.3%-99.8%+101.3%

TGTX ROE History

DateAnnualQuarterly
Jun 2025
-
27.34%(+38.2%)
Mar 2025
-
19.78%(+54.4%)
Dec 2024
12.21%(+5.5%)
12.81%(+252.5%)
Sep 2024
-
-8.40%(-112.3%)
Jun 2024
-
68.02%(+82.7%)
Mar 2024
-
37.23%(+165.4%)
Dec 2023
11.57%(+108.6%)
14.03%(+142.4%)
Sep 2023
-
-33.07%(+86.6%)
Jun 2023
-
-246.71%(-42.2%)
Mar 2023
-
-173.44%(-21.7%)
Dec 2022
-134.13%(-45.7%)
-142.56%(-13.3%)
Sep 2022
-
-125.81%(-7.4%)
Jun 2022
-
-117.16%(-11.1%)
Mar 2022
-
-105.49%(-14.9%)
Dec 2021
-92.03%(+8.1%)
-91.78%(+2.1%)
Sep 2021
-
-93.71%(+6.8%)
Jun 2021
-
-100.58%(+16.2%)
Mar 2021
-
-120.05%(+20.8%)
Dec 2020
-100.14%(+81.9%)
-151.59%(+50.5%)
Sep 2020
-
-306.54%(+34.7%)
Jun 2020
-
-469.39%(+78.2%)
Mar 2020
-
-2149.23%(-72.4%)
Dec 2019
-551.85%(-44.8%)
-1246.92%(-36.5%)
Sep 2019
-
-913.43%(-163.5%)
Jun 2019
-
-346.62%(-25.1%)
Mar 2019
-
-277.00%(-11.6%)
Dec 2018
-381.16%(-65.5%)
-248.27%(-33.6%)
Sep 2018
-
-185.83%(-3.2%)
Jun 2018
-
-180.08%(-11.9%)
Mar 2018
-
-161.00%(+1.8%)
Dec 2017
-230.36%(-102.3%)
-163.90%(-3.4%)
Sep 2017
-
-158.45%(-6.2%)
Jun 2017
-
-149.26%(-17.2%)
Mar 2017
-
-127.32%(-17.9%)
Dec 2016
-113.87%(-64.3%)
-107.98%(-32.5%)
Sep 2016
-
-81.52%(-33.3%)
Jun 2016
-
-61.14%(-3.5%)
Mar 2016
-
-59.09%(+2.9%)
Dec 2015
-69.30%(+25.4%)
-60.86%(+8.4%)
Sep 2015
-
-66.44%(+18.1%)
Jun 2015
-
-81.17%(+7.0%)
Mar 2015
-
-87.25%(+8.1%)
Dec 2014
-92.85%(-26.1%)
-94.94%(-15.0%)
Sep 2014
-
-82.56%(-11.8%)
Jun 2014
-
-73.83%(+0.5%)
Mar 2014
-
-74.20%(+9.3%)
Dec 2013
-73.66%(+64.6%)
-81.77%(+8.0%)
Sep 2013
-
-88.87%(+15.6%)
Jun 2013
-
-105.31%(-50.6%)
Mar 2013
-
-69.91%(+55.1%)
Dec 2012
-207.91%(-399.4%)
-155.75%(+28.3%)
Sep 2012
-
-217.30%(+15.1%)
Jun 2012
-
-255.86%(+42.2%)
Mar 2012
-
-442.54%(-2280.0%)
Dec 2011
-41.63%(-258.0%)
20.30%(+169.7%)
Sep 2011
-
-29.12%(+15.7%)
Jun 2011
-
-34.53%(+74.2%)
Mar 2011
-
-133.94%(-1210.6%)
DateAnnualQuarterly
Dec 2010
-11.63%(-128.2%)
-10.22%(-1758.2%)
Sep 2010
-
-0.55%(-108.7%)
Jun 2010
-
6.31%(-88.3%)
Mar 2010
-
53.78%(+19.1%)
Dec 2009
41.17%(-57.8%)
45.16%(+3.2%)
Sep 2009
-
43.77%(-34.6%)
Jun 2009
-
66.95%(-14.7%)
Mar 2009
-
78.51%(-40.5%)
Dec 2008
97.55%(+102.5%)
131.96%(-50.6%)
Sep 2008
-
267.38%(-64.0%)
Jun 2008
-
742.44%(+224.8%)
Mar 2008
-
-595.02%(-9.5%)
Dec 2007
-3922.51%(-2134.4%)
-543.46%(-30.1%)
Sep 2007
-
-417.84%(-39.0%)
Jun 2007
-
-300.55%(-52.7%)
Mar 2007
-
-196.82%(-6.9%)
Dec 2006
-175.55%(+35.8%)
-184.20%(-43.9%)
Sep 2006
-
-127.99%(+7.4%)
Jun 2006
-
-138.29%(+57.2%)
Mar 2006
-
-323.02%(+1.4%)
Dec 2005
-273.55%(-161.8%)
-327.72%(+7.8%)
Sep 2005
-
-355.33%(+13.2%)
Jun 2005
-
-409.36%(-310.9%)
Mar 2005
-
-99.63%(-18.2%)
Dec 2004
-104.48%(+86.2%)
-84.32%(+11.3%)
Sep 2004
-
-95.07%(+25.9%)
Jun 2004
-
-128.38%(+18.1%)
Mar 2004
-
-156.78%(+64.7%)
Dec 2003
-755.74%(-2667.9%)
-444.70%(-103.0%)
Sep 2003
-
14.73K%(+1850.7%)
Jun 2003
-
-841.65%(-298.6%)
Mar 2003
-
423.73%(+173.6%)
Dec 2002
29.43%(+138.5%)
154.87%(-44.1%)
Sep 2002
-
277.18%(-1.4%)
Jun 2002
-
281.12%(-50.6%)
Mar 2002
-
568.51%(+90.8%)
Dec 2001
-76.50%(+70.2%)
297.98%(+586.5%)
Sep 2001
-
-61.25%(-4.4%)
Jun 2001
-
-58.68%(+35.7%)
Mar 2001
-
-91.32%(+62.1%)
Dec 2000
-257.07%(-387.6%)
-241.26%(-19.4%)
Sep 2000
-
-202.00%(-27.6%)
Jun 2000
-
-158.31%(-110.7%)
Mar 2000
-
-75.15%(-35.3%)
Dec 1999
-52.72%(-34.6%)
-55.53%(+8.8%)
Sep 1999
-
-60.87%(+7.4%)
Jun 1999
-
-65.74%(-86.8%)
Mar 1999
-
-35.19%(+9.4%)
Dec 1998
-39.16%(+60.5%)
-38.83%(-5.6%)
Sep 1998
-
-36.76%(+5.7%)
Jun 1998
-
-39.00%(+59.6%)
Mar 1998
-
-96.55%(+11.3%)
Dec 1997
-99.05%(+42.2%)
-108.79%(+13.9%)
Sep 1997
-
-126.34%(+41.0%)
Jun 1997
-
-214.29%(-26.9%)
Mar 1997
-
-168.89%(-17.2%)
Dec 1996
-171.43%
-144.16%(-49.5%)
Sep 1996
-
-96.43%(-50.7%)
Jun 1996
-
-64.00%

FAQ

  • What is TG Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual ROE year-on-year change?
  • What is TG Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly ROE year-on-year change?

What is TG Therapeutics, Inc. annual return on equity?

The current annual ROE of TGTX is 12.21%

What is the all-time high annual ROE for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual return on equity is 97.55%

What is TG Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, TGTX annual return on equity has changed by +0.64% (+5.53%)

What is TG Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of TGTX is 27.34%

What is the all-time high quarterly ROE for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly return on equity is 14.73K%

What is TG Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, TGTX quarterly return on equity has changed by -40.68% (-59.81%)
On this page